SAN FR0000120578

Report

Real-time Euronext Paris - 11:39:51 2023-02-07 am EST
87.29	EUR		+2.80%

07:47a	SANOFI : JP Morgan reiterates its Buy rating	MD
02/06	SANOFI : Credit Suisse reaffirms its Buy rating	MD
02/06	French Stocks Kick Off Weak After US-China Diplomatic Relations Hit Snag	MT

SANOFI : UBS remains Neutral

12/01/2022 | 06:47am EST

UBS confirms his opinion on the stock and remains Neutral. The target price remains set at EUR 92.

All news about SANOFI

07:47a	SANOFI : JP Morgan reiterates its Buy rating	MD
02/06	SANOFI : Credit Suisse reaffirms its Buy rating	MD
02/06	French Stocks Kick Off Weak After US-China Diplomatic Relations Hit Snag	MT
02/06	SANOFI : Gets a Neutral rating from UBS	MD
02/06	SANOFI : Deutsche Bank sticks Neutral	MD
02/06	Describing "Everything, Everywhere, All At Once" For Genus Claims?	AQ
02/03	Health Care Edge Lower After Solid Earnings -- Health Care Roundup	DJ
02/03	Sanofi Sees Trend for Years of Steady Growth: CFO	MT
02/03	SANOFI : Goldman Sachs reiterates its Buy rating	MD
02/03	French Bourse Close Higher Friday as Private Sector Activity Remains Stable	MT

Analyst Recommendations on SANOFI

07:47a	SANOFI : JP Morgan reiterates its Buy rating	MD
02/06	SANOFI : Credit Suisse reaffirms its Buy rating	MD
02/06	SANOFI : Gets a Neutral rating from UBS	MD

Financials

Chart SANOFI

Duration : Period :

Technical analysis trends SANOFI

	Short Term	Mid-Term	Long Term
Trends	Bearish	Neutral	Neutral

Income Statement Evolution

More Financials

Consensus

EPS Revisions

More Estimates Revisions

Managers and Directors

Paul Hudson	Chief Executive Officer & Director
Jean-Baptiste Chasseloup de Chatillon	Chief Financial Officer & Executive Vice President
Serge Weinberg	Director
John C. Reed	EVP & Global Head-Research & Development
Nestle Frank	Global Head-Immunology Therapeutic Research Area

Sector and Competitors

		1st jan.	Capi. (M$)
	SANOFI	-5.49%	113 718

SANOFI